Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma

被引:2
作者
Yamaguchi, Yoshitomo [1 ]
Yokoyama, Minato [1 ]
Takemoto, Akira [2 ]
Nakamura, Yuki [1 ]
Fukuda, Shohei [1 ]
Uehara, Sho [1 ]
Tanaka, Hajime [1 ]
Yoshida, Soichiro [1 ]
Matsuoka, Yoh [1 ]
Fujii, Yasuhisa [1 ]
机构
[1] Tokyo Med & Dent Univ, Dept Urol, 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan
[2] Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan
关键词
anaerobic metabolism; paraganglioma; pheochromocytoma; renal cell cancer; succinate dehydrogenase; PHEOCHROMOCYTOMA; EXPRESSION; TUMORS;
D O I
10.1002/iju5.12520
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: SDH Gene mutation is known to be a common cause of pheochromocytoma/paraganglioma and renal cell carcinoma. Here, we report a case of succinate dehydrogenase B-deficient paraganglioma, which has a high risk of metastasis and recurrence, complicated by succinate dehydrogenase-deficient renal cell carcinoma, which is rare and accounts for approximately 0.1% of all renal cell carcinomas. Case presentation: A 50-year-old man underwent en bloc resection of a retroperitoneal tumor and the right kidney for retroperitoneal paraganglioma and right renal tumor. Both tumors showed negative expressions of succinate dehydrogenase B in immunostaining. The patient was diagnosed with succinate dehydrogenase-deficient paraganglioma and succinate dehydrogenase-deficient renal cell carcinoma. Seventeen months later, retroperitoneal lymphadenectomy revealed lymph node metastasis of the paraganglioma. Deletion of the SDHB gene was revealed by genome sequencing of the lymph node. Conclusion: This is the first reported case of synchronously diagnosed succinate dehydrogenase-deficient paraganglioma and succinate dehydrogenase-deficient renal cell carcinoma.
引用
收藏
页码:480 / 483
页数:4
相关论文
共 14 条
  • [1] Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity A Clinicopathologic Series of 36 Tumors From 27 Patients
    Gill, Anthony J.
    Hes, Ondrej
    Papathomas, Thomas
    Sedivcova, Monika
    Tan, Puay Hoon
    Agaimy, Abbas
    Andresen, Per Arne
    Kedziora, Andrew
    Clarkson, Adele
    Toon, Christopher W.
    Sioson, Loretta
    Watson, Nicole
    Chou, Angela
    Paik, Julie
    Clifton-Bligh, Roderick J.
    Robinson, Bruce G.
    Benn, Diana E.
    Hills, Kirsten
    Maclean, Fiona
    Niemeijer, Nicolasine D.
    Vlatkovic, Ljiljana
    Hartmann, Arndt
    Corssmit, Eleonora P. M.
    van Leenders, Geert J. L. H.
    Przybycin, Christopher
    McKenney, Jesse K.
    Magi-Galluzzi, Cristina
    Yilmaz, Asli
    Yu, Darryl
    Nicoll, Katherine D.
    Yong, Jim L.
    Sibony, Mathilde
    Yakirevich, Evgeny
    Fleming, Stewart
    Chow, Chung W.
    Miettinen, Markku
    Michal, Michal
    Trpkov, Kiril
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (12) : 1588 - 1602
  • [2] Rationale and Evidence for Sunitinib in the Treatment of Malignant Paraganglioma/Pheochromocytoma
    Joshua, Anthony M.
    Ezzat, Shereen
    Asa, Sylvia L.
    Evans, Andrew
    Broom, Reuben
    Freeman, Marc
    Knox, Jennifer J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01) : 5 - 9
  • [3] Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
    Kimura, Noriko
    Takayanagi, Ryoichi
    Takizawa, Nae
    Itagaki, Eiji
    Katabami, Takayuki
    Kakoi, Narihiko
    Rakugi, Hiromi
    Ikeda, Yukihiro
    Tanabe, Akiyo
    Nigawara, Takeshi
    Ito, Sadayoshi
    Kimura, Itaru
    Naruse, Mitsuhide
    [J]. ENDOCRINE-RELATED CANCER, 2014, 21 (03) : 405 - 414
  • [4] The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
    Moch, Holger
    Cubilla, Antonio L.
    Humphrey, Peter A.
    Reuter, Victor E.
    Ulbright, Thomas M.
    [J]. EUROPEAN UROLOGY, 2016, 70 (01) : 93 - 105
  • [5] Pheochromocytoma and Paraganglioma
    Neumann, Hartmut P. H.
    Young, William F., Jr.
    Eng, Charis
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (06) : 552 - 565
  • [6] Germ-line mutations in nonsyndromic pheochromocytoma.
    Neumann, HPH
    Bausch, B
    McWhinney, SR
    Bender, BU
    Gimm, O
    Franke, G
    Schipper, J
    Klisch, J
    Altehoefer, C
    Zerres, K
    Januszewicz, A
    Smith, WM
    Munk, R
    Manz, T
    Glaesker, S
    Apel, TW
    Treier, M
    Reineke, M
    Walz, MK
    Hoang-Vu, C
    Brauckhoff, M
    Klein-Franke, A
    Klose, P
    Schmidt, H
    Maier-Woelfle, M
    Peczkowska, M
    Szmigielski, C
    Eng, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (19) : 1459 - 1466
  • [7] Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943
  • [8] Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis
    Niemeijer, N. D.
    Alblas, G.
    van Hulsteijn, L. T.
    Dekkers, O. M.
    Corssmit, E. P. M.
    [J]. CLINICAL ENDOCRINOLOGY, 2014, 81 (05) : 642 - 651
  • [9] The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
    Peng, Song
    Zhang, Jun
    Tan, Xintao
    Huang, Yiqiang
    Xu, Jing
    Silk, Natalie
    Zhang, Dianzheng
    Liu, Qiuli
    Jiang, Jun
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [10] Expression of HIF-1α, HIF-2α (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations
    Pollard, Patrick J.
    El-Bahrawy, Mona
    Poulsom, Richard
    Elia, George
    Killick, Pip
    Kelly, Gavin
    Hunt, Toby
    Jeffery, Rosemary
    Seedhar, Pooja
    Barwell, Julian
    Latif, Farida
    Gleeson, Michael J.
    Hodgson, Shirley V.
    Stamp, Gordon W.
    Tomlinson, Ian P. M.
    Maher, Eamonn R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) : 4593 - 4598